U.S. Marine and Shipping Stock News

Costco Wholesale (NasdaqGS:COST) has rolled out a new digital wallet feature within its mobile app for members. The wallet allows members to link any Visa card for streamlined in-store checkout. This update represents a material change to Costco's digital member experience and payment options. Costco Wholesale operates a membership based warehouse retail model, with a focus on bulk purchases and a relatively simple in store format. As large retailers invest more in mobile apps and...

BellRing Brands stock has had a tough run over the past year, yet the current valuation checks suggest the shares may now be pricing in a lot of that weakness. Over the last 12 months, BellRing Brands has declined 79.2%, which puts a sharp reset in expectations front and center for any valuation view. Investors now have to weigh a leadership change, with Michael C. Axelrod taking over as CEO, against the overhang from a securities lawsuit that questions how past sales trends were...

Willis Towers Watson stock has delivered a 39.3% total return over the past 5 years, yet the current valuation picture is split, with the Excess Returns intrinsic value estimate pointing to upside while market multiples lean the other way. A 39.3% return over 5 years suggests Willis Towers Watson has rewarded patient shareholders, even though shorter term performance has recently been more subdued. Expansion in areas like cyber insurance and digital asset coverage can support growth...

In late June 2026, Tanger Inc. (NYSE: SKT) was removed from the Russell 2000 Dynamic Index, a change that typically drives portfolio rebalancing by index-tracking investors and funds. This index removal could reshape how both passive and active investors view Tanger’s role in retail REIT allocations and trading liquidity. We’ll now examine how Tanger’s removal from the Russell 2000 Dynamic Index may influence its investment narrative and longer-term positioning. We've uncovered the 9...

The Morning Bull - US Market Morning Update Friday, Jul, 10 2026 US stock futures are slightly higher this morning, with E mini S&P 500 contracts up about 0.2%, as investors weigh stubborn borrowing costs and fresh signs of inflation pressure. The US 10 year Treasury yield is holding near 4.58%, meaning mortgages, car loans and business borrowing remain relatively expensive. Oil related price moves are feeding worries that the cost of living could stay higher for longer and keep interest rate...

Centrus Energy (NYSE:LEU) has secured a $900 million fixed price contract with the U.S. Department of Energy. The agreement covers commercial production of High Assay, Low Enriched Uranium (HALEU) for advanced nuclear fuel. The deal marks a shift for Centrus from a government backed demonstration project to commercial scale enrichment. Centrus Energy moves into this new contract with the stock trading at $173.56 and a mixed recent track record. NYSE:LEU is up 7.0% over the past week and...

LCI Industries stock is down about 18% year to date, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount. This sits against the backdrop of a planned all stock merger with Patrick Industries that will eventually swap each LCI share into Patrick stock. With the share price down 18% so far this year, the current valuation is being set by a market that has turned more cautious on LCI Industries despite a...

Kite Realty Group Trust (NYSE:KRG) was removed from the Russell 2000 Dynamic Index in late June 2026, a change that can affect how index-tracking funds allocate capital to the stock. This index removal brings passive ownership and liquidity into sharper focus for Kite Realty Group, adding a new layer of consideration to its existing retail REIT thesis. We will now examine how Kite Realty Group’s exit from the Russell 2000 Dynamic Index may influence its existing investment narrative and risk...

Nelnet (NNI) is back in focus after reporting quarterly revenue of $353.2 million, a decline of 7.1% year on year. This result missed expectations and coincided with a 6.1% share price decline since the earnings release. See our latest analysis for Nelnet. Zooming out from the latest quarter, Nelnet’s 1-year total shareholder return of 6.2% and 3-year total shareholder return of 41.1% suggest longer term holders have still seen gains, even as near term share price momentum has cooled. If this...

In late June 2026, Alto Ingredients, Inc. was added to multiple Russell equity and value indexes, including the Russell 2000, Russell 3000, Russell 2500, and related microcap and value benchmarks, while also partnering on a US$16 million Illinois River infrastructure project to enhance barge-based product transport and storage. This combination of broader index inclusion and investment in river logistics infrastructure highlights Alto Ingredients’ growing institutional visibility and efforts...

In late June 2026, Establishment Labs Holdings Inc. was added to a broad suite of Russell indexes, including the Russell 2000, Russell 3000, and several related growth and small-cap benchmarks, and also appointed veteran healthcare executive and former Cutera CEO Taylor Harris to its Board and key board committees. Harris’s track record in corporate finance, acquisitions, and medtech leadership, combined with the company’s new presence across multiple Russell indexes, could reshape how both...

Big pharma is funding a field it once dismissed. These three psychedelic stocks carry possible clinical catalysts as the healthcare industry turns to alternative medicines.

Billions in prepaid spending flow through this corner of the market every year. Here are three US small-cap stocks positioned to capture it.

In late June 2026, BioAge Labs, Inc. (NasdaqGS:BIOA) was added to multiple Russell Growth Benchmark Indexes, including the Russell 2000, Russell 2500, Russell 3000, Russell 3000E, Russell Microcap, and the Russell Small Cap Comp Growth indexes. This broad index inclusion significantly expands BioAge Labs’ visibility among institutional investors and index-tracking funds that follow these Russell Growth benchmarks. Next, we’ll examine how BioAge Labs’ broad Russell Growth index inclusion...

Index changes put Birkenstock Holding in focus Birkenstock Holding (BIRK) has been removed from several Russell growth benchmarks, a shift that can trigger portfolio rebalancing by index-tracking funds and influence short term trading in the stock. See our latest analysis for Birkenstock Holding. Against this backdrop, Birkenstock Holding’s share price has moved to US$45.32, with a 1 day share price return of 2.44% and a 90 day share price return of 19.17%, while the 1 year total shareholder...

Why Marzetti Stock Is Back on Investors’ Radar Marzetti (MZTI) has attracted fresh attention after being added to several Russell value indices, a change that can affect how many index funds and benchmarked portfolios hold the stock. See our latest analysis for Marzetti. Despite its index additions and the appointment of a new Chief Supply Chain Officer, Marzetti’s short term share price return has been mixed. The stock is down year to date and the 1 year total shareholder return has also...

Tariff headlines are back in focus, and this time the pressure is squarely on import costs for U.S. consumers and businesses. With Virginia and other states pushing back against broad U.S. tariffs, investors are weighing what heavier trade frictions and higher prices could mean for different parts of the market. Domestic focused stocks that rely less on imported inputs can appear relatively insulated when trade tensions rise, while others may face higher cost pressure or sentiment swings...

In recent days, First Industrial Realty Trust reported strong Q1 2026 results, with earnings per share of US$1.08 significantly exceeding forecasts, and attracted renewed coverage from several investment firms highlighting demand for its logistics properties. This combination of outperformance against expectations and fresh analyst attention has sharpened the focus on how First Industrial is positioned within the industrial real estate market. With Q1 earnings materially ahead of forecasts,...

Pure Cycle (PCYO) has posted its Q3 2026 numbers with total revenue of about US$8.2 million and basic EPS of US$0.12, set against trailing twelve month revenue of roughly US$33.7 million and EPS of US$0.61, underpinned by 8.2% earnings growth over the past year. Over recent quarters, the company has seen revenue move from around US$5.2 million with EPS of US$0.03 in Q2 2025 to US$11.2 million with EPS of US$0.25 in Q4 2025, then to US$8.2 million and EPS of US$0.12 in Q3 2026. This has left...

Butler National (BUKS) has put up a clean set of FY 2026 numbers, with fourth quarter revenue at US$27.7 million and basic EPS of US$0.09, alongside trailing twelve month revenue of US$98.0 million and EPS of US$0.34 that sit against reported earnings growth of 74.8% over the past year. Over recent periods the company has seen revenue progress from US$83.97 million on a trailing basis in FY 2025 to US$98.0 million in FY 2026. EPS over the same trailing window moved from US$0.19 to US$0.34,...

Wayfair's share price has rebounded in the last year, but with the stock still down 68.5% over five years and screening as overvalued on market multiples, the current level raises questions about how much of the recovery story is already reflected in the price. Over the past five years, Wayfair has delivered a total return that is down 68.5%, which highlights how deep the earlier drawdown was despite the more recent strength. Recent optimism around improving earnings expectations can support...

PriceSmart (PSMT) has released its Q3 2026 results, reporting revenue of about US$1.5b, basic EPS of roughly US$1.31 and net income, excluding extra items, of US$39.7m. The company’s quarterly revenue has moved from US$1.33b in Q4 2025 to US$1.38b in Q1 2026, US$1.50b in Q2 2026 and US$1.48b in Q3 2026. Over the same period, basic EPS ranged from US$1.02 to US$1.62, giving investors a clear view of top line scale and earnings power to track. With trailing 12 month EPS of about US$5.22 and a...

Arbutus Biopharma stock has delivered a strong 126.4% return over the past three years, yet its current valuation checks and market multiples suggest the shares are not a clear bargain at recent levels. Over the last three years, Arbutus Biopharma has returned 126.4%, which puts extra focus on whether the current share price already reflects much of the good news investors are hoping for. Expectations around the company’s ability to turn its pipeline and research into durable cash flows can...

AZZ (AZZ) has opened fiscal 2027 with Q1 revenue of $448.5 million and basic EPS of $1.74, setting the tone for how its earnings story is evolving after a mixed year of growth and margin shifts. The company has seen quarterly revenue move from $421.9 million and EPS of $5.71 in Q1 2026 to $448.5 million and $1.74 in Q1 2027, against a backdrop where trailing 12 month EPS was $6.62 and net income was $198.4 million. This frames a results season in which investors are watching how profit...